Cargando…
Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
BACKGROUND: Deceased donor kidneys for transplantation are in most countries allocated preferentially to recipients who have limited co-morbidities. Little is known about the incremental health and economic gain from transplanting those with co-morbidities compared to remaining on dialysis. The aim...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261160/ https://www.ncbi.nlm.nih.gov/pubmed/22279541 http://dx.doi.org/10.1371/journal.pone.0029591 |
_version_ | 1782221562120765440 |
---|---|
author | Wong, Germaine Howard, Kirsten Chapman, Jeremy R. Chadban, Steven Cross, Nicholas Tong, Allison Webster, Angela C. Craig, Jonathan C. |
author_facet | Wong, Germaine Howard, Kirsten Chapman, Jeremy R. Chadban, Steven Cross, Nicholas Tong, Allison Webster, Angela C. Craig, Jonathan C. |
author_sort | Wong, Germaine |
collection | PubMed |
description | BACKGROUND: Deceased donor kidneys for transplantation are in most countries allocated preferentially to recipients who have limited co-morbidities. Little is known about the incremental health and economic gain from transplanting those with co-morbidities compared to remaining on dialysis. The aim of our study is to estimate the average and incremental survival benefits and health care costs of listing and transplantation compared to dialysis among individuals with varying co-morbidities. METHODS: A probabilistic Markov model was constructed, using current outcomes for patients with defined co-morbidities treated with either dialysis or transplantation, to compare the health and economic benefits of listing and transplantation with dialysis. FINDINGS: Using the current waiting time for deceased donor transplantation, transplanting a potential recipient, with or without co-morbidities achieves survival gains of between 6 months and more than three life years compared to remaining on dialysis, with an average incremental cost-effectiveness ratio (ICER) of less than $50,000/LYS, even among those with advanced age. Age at listing and the waiting time for transplantation are the most influential variables within the model. If there were an unlimited supply of organs and no waiting time, transplanting the younger and healthier individuals saves the most number of life years and is cost-saving, whereas transplanting the middle-age to older patients still achieves substantial incremental gains in life expectancy compared to being on dialysis. CONCLUSIONS: Our modelled analyses suggest transplanting the younger and healthier individuals with end-stage kidney disease maximises survival gains and saves money. Listing and transplanting those with considerable co-morbidities is also cost-effective and achieves substantial survival gains compared with the dialysis alternative. Preferentially excluding the older and sicker individuals cannot be justified on utilitarian grounds. |
format | Online Article Text |
id | pubmed-3261160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32611602012-01-25 Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities Wong, Germaine Howard, Kirsten Chapman, Jeremy R. Chadban, Steven Cross, Nicholas Tong, Allison Webster, Angela C. Craig, Jonathan C. PLoS One Research Article BACKGROUND: Deceased donor kidneys for transplantation are in most countries allocated preferentially to recipients who have limited co-morbidities. Little is known about the incremental health and economic gain from transplanting those with co-morbidities compared to remaining on dialysis. The aim of our study is to estimate the average and incremental survival benefits and health care costs of listing and transplantation compared to dialysis among individuals with varying co-morbidities. METHODS: A probabilistic Markov model was constructed, using current outcomes for patients with defined co-morbidities treated with either dialysis or transplantation, to compare the health and economic benefits of listing and transplantation with dialysis. FINDINGS: Using the current waiting time for deceased donor transplantation, transplanting a potential recipient, with or without co-morbidities achieves survival gains of between 6 months and more than three life years compared to remaining on dialysis, with an average incremental cost-effectiveness ratio (ICER) of less than $50,000/LYS, even among those with advanced age. Age at listing and the waiting time for transplantation are the most influential variables within the model. If there were an unlimited supply of organs and no waiting time, transplanting the younger and healthier individuals saves the most number of life years and is cost-saving, whereas transplanting the middle-age to older patients still achieves substantial incremental gains in life expectancy compared to being on dialysis. CONCLUSIONS: Our modelled analyses suggest transplanting the younger and healthier individuals with end-stage kidney disease maximises survival gains and saves money. Listing and transplanting those with considerable co-morbidities is also cost-effective and achieves substantial survival gains compared with the dialysis alternative. Preferentially excluding the older and sicker individuals cannot be justified on utilitarian grounds. Public Library of Science 2012-01-18 /pmc/articles/PMC3261160/ /pubmed/22279541 http://dx.doi.org/10.1371/journal.pone.0029591 Text en Wong et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Wong, Germaine Howard, Kirsten Chapman, Jeremy R. Chadban, Steven Cross, Nicholas Tong, Allison Webster, Angela C. Craig, Jonathan C. Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities |
title | Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities |
title_full | Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities |
title_fullStr | Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities |
title_full_unstemmed | Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities |
title_short | Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities |
title_sort | comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261160/ https://www.ncbi.nlm.nih.gov/pubmed/22279541 http://dx.doi.org/10.1371/journal.pone.0029591 |
work_keys_str_mv | AT wonggermaine comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities AT howardkirsten comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities AT chapmanjeremyr comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities AT chadbansteven comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities AT crossnicholas comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities AT tongallison comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities AT websterangelac comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities AT craigjonathanc comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities |